Skip to main content

Recommended

Services

    PI Leaflets

      Pages

        No results found.

        News stories

        New Midlands roadmap to improve treatment information and choice for patients with bleeding disorders

        Published on 29/05/2026

        Sponsor declaration

        Roche Products Ltd. and Chugai Pharma UK Ltd., and Takeda UK Limited, have provided financial support for the Pan-Midlands Service Evaluation Initiative and have had no involvement in the project.

        A major new Midlands-wide evaluation has highlighted opportunities to strengthen how people living with inherited bleeding disorders are supported to understand and make decisions about their treatment. 

        The “Bridging the Gap” report, published in May 2026, brings together insights from University Hospitals Birmingham NHS Foundation Trust, University Hospitals of Leicester and Nottingham University Hospitals.  

        Drawing on the responses from over 200 patients and carers, the evaluation explores how treatment information is accessed, understood and used across the region’s haemophilia comprehensive care centres (CCCs).  

        The findings show that while most people feel confident engaging with their clinical teams, many have trouble when it comes to evaluating and comparing treatment options. Nearly one in three respondents reported uncertainty in weighing up different approaches, despite high levels of confidence in discussion and understanding.  

        The report highlights a strong reliance by patients on their clinical teams as the primary source of information, with 73% of respondents identifying their multidisciplinary team as their main point of reference and 88% preferring verbal explanations during clinic visits.  

        While this reflects high levels of trust, it points to the need for more structured, accessible and personalised approaches to support shared decision making beyond the consultation.  

        There is also clear demand for more information about new and emerging treatments, with two-thirds of respondents wanting to learn more about developments in care, alongside interest in side effects, safety and how treatments work in practice.  

        Clinical leaders from the three centres emphasise in the report the importance of ensuring that information is accessible, meaningful and responsive to the needs of a diverse population. They note that while many people feel confident engaging with services, “there is more we can do to support individuals in critically appraising their treatment options,” and to ensure everyone can participate meaningfully in decisions about their care.  

        The report sets out a series of recommendations focused on improving communication, strengthening health literacy, embedding practical decision-making tools and addressing inequalities in access to information.

        You can read the findings on our website.

         

        More news

        Celebrating 25 years of the NIHR Birmingham Clinical Research Facility

        Celebrating 25 years of the NIHR Birmingham Clinical Research Facility

        This year, we are celebrating 25 years of the National Institute for Health and Care Research (NIHR) Birmingham Clinical Research Facility (CRF) at Queen Elizabeth Hospital Birmingham (QEHB). The milestone was marked with a special anniversary event, bringing together current and former colleagues who have played a role in the CRF's success over the years.
        Heartlands conference puts research at the heart of tackling health inequalities

        Heartlands conference puts research at the heart of tackling health inequalities

        The first two-day Heartlands Research and Quality Improvement Conference has been hailed a success. More than 200 colleagues came together at the start of October to celebrate and share research and quality improvement projects that are taking place at Heartlands Hospital.
        National fellowship marks major step for early-phase dementia research in Birmingham

        National fellowship marks major step for early-phase dementia research in Birmingham

        University Hospitals Birmingham (UHB) is set to strengthen its role in dementia research following the award of a prestigious UK Dementia Trials Network (UKDTN) Clinical Trials Fellowship to consultant neurologist Dr Will Scotton.
        Read more news